International generic name

Combined product

Drug form and composition

Ointment. 1 gr ointment contains 0.05 g Undecylenic acid and 0.2 g Zinc undecylenic.

Indications

The preparation is indicated in epidermal mycosis (interdigital and inguinal) and candidiasis.

Dosage and administration

Affected regions are treated 1-2 times daily. It is advisable the treatment to continue one month. The treatment should be continued 2-4 weeks after the clinical manifestations are resolved with 1-2 applications weekly.

Contraindications

The preparation should not be used in hypersensitivity to any of active constituents of the preparation and on children younger than 2 years.

Special warnings and precautions

Mycodermin should not be applied in the eyes and in opened wounds. It should be used with care in patients with diabetes.

Drug interactions

No clinically significant adverse drug interactions were seen so far.

Adverse reactions

In local application in some cases the preparation may cause itching, redness, burning, and rashes.

Pharmacological mechanisms

Mycodermin ointment is an antimycotic preparation with broad spectrum of action for dermatology use. Undecylenic acid and its zinc salt are active in superficial mycoses, caused by dermatophytes, yeast, moulds, and some Gram-positive microorganisms. The fungicid effect of the preparation is due to the pathogen fungi lipid exchange deterioration.

Supplied

Tube, containing 18 g ointment.

Expiry

3 years.